Designing Therapies for Solid Tumour Indications to Enhance Efficacy in the Microenvironment In Vivo

Time: 3:30 pm
day: Day One


  • Overview of first-in-class learnings for gamma-delta CAR-T cells
  • Discuss areas for further leveraging, enhancing, and targeting gamma-delta T cells in solid malignancies
  • Reprogramming innate signalling capabilities to augment potency for gammadelta T cells in solid tumours